Affordable Access

Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.

Authors
  • Koncz, G1
  • Pecht, I
  • Gergely, J
  • Sármay, G
  • 1 Research Group of the Hungarian Academy of Science at the Department of Immunology, L. Eötvös University, Göd.
Type
Published Article
Journal
European journal of immunology
Publication Date
Jun 01, 1999
Volume
29
Issue
6
Pages
1980–1989
Identifiers
PMID: 10382761
Source
Medline
License
Unknown

Abstract

Co-clustering of the type II receptors binding the Fc part of IgG (FcgammaRIIb) and B cell receptors results in the translocation of cytosolic, negative regulatory molecules to the phosphorylated immunoreceptor tyrosine-based inhibitory motif (P-ITIM) of the FcgammaRIIb. SH2 domain-containing protein tyrosine phosphatases (SHP-1 and SHP-2), and the polyphosphoinositol 5'-phosphatase (SHIP) have been reported earlier to bind to murine FcgammaRIIb P-ITIM. However, neither the functional substrates of these enzymes, nor the mechanism of the inhibition are fully resolved. We show here that the human FcgammaRIIb binds SHP-2 when co-clustered with the B cell receptors, whereas its synthetic P-ITIM peptide bindes SHP-2 and SHIP in lysates of the Burkitt's lymphoma cell line BL41. The P-ITIM peptide binding enhances SHP-2 activity, resulting in dephosphorylation and release of P-ITIM-bound SHIP and Shc. Moreover, P-ITIM-bound SHP-2 dephosphorylates synthetic peptides corresponding to the sites of tyrosine phosphorylation on SHIP and Shc, indicating that these proteins are its potential substrates. Thus SHP-2-induced dephosphorylation may modulate the intracellular localization and/or activity of SHIP and Shc, thereby inhibiting further activation pathways which they mediate.

Report this publication

Statistics

Seen <100 times